From Prodromal to Preclinical: Detecting Amyloid‐Beta Through Mobile Gaze Analysis

SCT and Gaze Instability measurements demonstrated effective differentiation in mobile contexts. The redefined self-correction parameters and Gaze Instability metrics, combined with the RCF phase, enhanced measurement precision under ambient noise. These methodological advances established an economical approach for amyloid pathology detection. Enabling potential applications for earlier Aβ identification at preclinical AD stages, it presented opportunities for expedited clinical intervention and refined disease management protocols.